
Cost–effectiveness of empagliflozin compared with liraglutide based on cardiovascular outcome trials in Type II diabetes
Author(s) -
Mafalda Ramos,
Anastasia Ustyugova,
N. Hau,
Mark Lamotte
Publication year - 2020
Publication title -
journal of comparative effectiveness research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.567
H-Index - 23
eISSN - 2042-6313
pISSN - 2042-6305
DOI - 10.2217/cer-2020-0071
Subject(s) - empagliflozin , liraglutide , medicine , type 2 diabetes , diabetes mellitus , clinical trial , endocrinology